Diffusion kernel-based predictive modeling of KRAS dependency in KRAS wild type cancer cell lines.

Abstract excerpt

Recent progress in clinical development of KRAS inhibitors has raised interest in predicting the tumor dependency on frequently mutated RAS-pathway oncogenes. However, even without such activating mutations, RAS proteins represent core components in signal integration of several membrane-bound kinases. This raises the question of applications of specific inhibitors independent from the mutational status. Here, we...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Line
• Share to Mutation
• Share to Neoplasms